Previous reports from our laboratory have identified the efficacy of SF in claudin-low SUM159 is similar to these transformed PTEN deficient breast cancer cells31, which is significantly different when compared to that of HER2 amplified BT474. The gene discussed is ERBB2; the disease is breast cancer.